Schedule 13G ownership disclosure
ADAPTIMMUNE THERAPEUTICS PLC
Ordinary Shares, par value GBP 0.001 per share · CUSIP: 00653A107
Event date: 2025-03-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Two Seas Capital LP
Shares: 123,178,110 · Class: 8%
- Two Seas Capital GP LLC
Shares: 123,178,110 · Class: 8%
- Sina Toussi
Shares: 123,178,110 · Class: 8%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001315863-25-000391
- Form type
- SCHEDULE 13G/A
- Filer
- Adaptimmune Therapeutics PLC
- CIK
- CIK 1621227
- Filed
- May 15, 2025
- Reporting period
- Mar 31, 2025
- Description
- Schedule 13G beneficial ownership